跳转至内容
Merck
CN
  • Oral administration of morphine versus ibuprofen to manage postfracture pain in children: a randomized trial.

Oral administration of morphine versus ibuprofen to manage postfracture pain in children: a randomized trial.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne (2014-10-29)
Naveen Poonai, Gina Bhullar, Kangrui Lin, Adam Papini, David Mainprize, Jocelyn Howard, John Teefy, Michelle Bale, Cindy Langford, Rodrick Lim, Larry Stitt, Michael J Rieder, Samina Ali
摘要

Recent warnings from Health Canada regarding codeine for children have led to increased use of nonsteroidal anti-inflammatory drugs and morphine for common injuries such as fractures. Our objective was to determine whether morphine administered orally has superior efficacy to ibuprofen in fracture-related pain. We used a parallel group, randomized, blinded superiority design. Children who presented to the emergency department with an uncomplicated extremity fracture were randomly assigned to receive either morphine (0.5 mg/kg orally) or ibuprofen (10 mg/kg) for 24 hours after discharge. Our primary outcome was the change in pain score using the Faces Pain Scale - Revised (FPS-R). Participants were asked to record pain scores immediately before and 30 minutes after receiving each dose. We analyzed data from 66 participants in the morphine group and 68 participants in the ibuprofen group. For both morphine and ibuprofen, we found a reduction in pain scores (mean pre-post difference ± standard deviation for dose 1: morphine 1.5 ± 1.2, ibuprofen 1.3 ± 1.0, between-group difference [δ] 0.2 [95% confidence interval (CI) -0.2 to 0.6]; dose 2: morphine 1.3 ± 1.3, ibuprofen 1.3 ± 0.9, δ 0 [95% CI -0.4 to 0.4]; dose 3: morphine 1.3 ± 1.4, ibuprofen 1.4 ± 1.1, δ -0.1 [95% CI -0.7 to 0.4]; and dose 4: morphine 1.5 ± 1.4, ibuprofen 1.1 ± 1.2, δ 0.4 [95% CI -0.2 to 1.1]). We found no significant differences in the change in pain scores between morphine and ibuprofen between groups at any of the 4 time points (p = 0.6). Participants in the morphine group had significantly more adverse effects than those in the ibuprofen group (56.1% v. 30.9%, p < 0.01). We found no significant difference in analgesic efficacy between orally administered morphine and ibuprofen. However, morphine was associated with a significantly greater number of adverse effects. Our results suggest that ibuprofen remains safe and effective for outpatient pain management in children with uncomplicated fractures. ClinicalTrials.gov, no. NCT01690780.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
布洛芬, ≥98% (GC)
Supelco
布洛芬, Pharmaceutical Secondary Standard; Certified Reference Material
USP
布洛芬, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
( S )-(+)-布洛芬, ReagentPlus®, 99%
布洛芬, European Pharmacopoeia (EP) Reference Standard
Supelco
布洛芬
Supelco
布洛芬 钠盐, ≥98% (GC)
布洛芬, European Pharmacopoeia (EP) Reference Standard
Supelco
Ibuprofen 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
布洛芬, meets USP testing specifications